FORM 10-K

Company

Outlook Therapeutics, Inc.

Filed

December 19, 2019

Period of Report

September 30, 2019

Accession Number

0001104659-19-074095

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →